Insulin-producing cells from tissue stem/progenitor cells: are autologous cells preferable to allogeneic?
作者信息
Efrat Shimon
出版信息
Rev Diabet Stud. 2005 Spring;2(1):6-8. doi: 10.1900/RDS.2005.2.6. Epub 2005 May 10.
Abstract
摘要
相似文献
1
Insulin-producing cells from tissue stem/progenitor cells: are autologous cells preferable to allogeneic?
Rev Diabet Stud. 2005 Spring;2(1):6-8. doi: 10.1900/RDS.2005.2.6. Epub 2005 May 10.
2
Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
Methods Mol Biol. 2007;368:237-59. doi: 10.1007/978-1-59745-362-2_17.
3
Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.
Biol Blood Marrow Transplant. 2007 Apr;13(4):433-9. doi: 10.1016/j.bbmt.2006.11.016. Epub 2007 Feb 15.
4
Mesenchymal stem cell therapy in treatment of erectile dysfunction: autologous or allogeneic cell sources?
Int J Urol. 2014 Dec;21(12):1280-5. doi: 10.1111/iju.12585. Epub 2014 Jul 30.
5
Comparison of autologous versus allogeneic epithelial-like stem cell treatment in an in vivo equine skin wound model.
Cytotherapy. 2015 Oct;17(10):1434-46. doi: 10.1016/j.jcyt.2015.06.004. Epub 2015 Jul 23.
6
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.
EBioMedicine. 2015 Mar 28;2(5):467-75. doi: 10.1016/j.ebiom.2015.03.020. eCollection 2015 May.
7
T-cell subsets in autologous and allogeneic peripheral blood stem cell concentrates.
Vox Sang. 2015 Nov;109(4):375-86. doi: 10.1111/vox.12289. Epub 2015 Jun 3.
8
Wound-healing markers after autologous and allogeneic epithelial-like stem cell treatment.
Cytotherapy. 2016 Apr;18(4):562-9. doi: 10.1016/j.jcyt.2016.01.008.
9
[Effect of Autologous or Allogeneic Anti-CD3 Monoclonal Antibody Activated Killer Cells on Normal Hematopoietic Cells].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2001 Dec;9(4):338-342.
10
Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):99-106. doi: 10.1016/j.vetimm.2013.09.003. Epub 2013 Sep 18.
本文引用的文献
1
Encapsulated, genetically modified cells producing in vivo therapeutics.
Curr Opin Mol Ther. 2004 Aug;6(4):412-20.
2
Bone marrow-derived stem cells initiate pancreatic regeneration.
Nat Biotechnol. 2003 Jul;21(7):763-70. doi: 10.1038/nbt841. Epub 2003 Jun 22.
3
Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells.
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7253-8. doi: 10.1073/pnas.1136854100. Epub 2003 May 19.
4
NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice.
Nat Med. 2003 May;9(5):596-603. doi: 10.1038/nm867. Epub 2003 Apr 21.
5
In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion.
J Clin Invest. 2003 Mar;111(6):843-50. doi: 10.1172/JCI16502.
6
Experimental conversion of liver to pancreas.
Curr Biol. 2003 Jan 21;13(2):105-15. doi: 10.1016/s0960-9822(02)01434-3.
7
Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells.
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):998-1003. doi: 10.1073/pnas.0237371100. Epub 2003 Jan 13.
8
Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells.
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16105-10. doi: 10.1073/pnas.252618999. Epub 2002 Nov 19.
9
Cell replacement therapy for type 1 diabetes.
Trends Mol Med. 2002 Jul;8(7):334-39. doi: 10.1016/s1471-4914(02)02365-1.
10
Pluripotency of mesenchymal stem cells derived from adult marrow.
Nature. 2002 Jul 4;418(6893):41-9. doi: 10.1038/nature00870. Epub 2002 Jun 20.
Zotero 插件